Clinical Trial Update: A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of Avastin (bevacizumab) in patients with inflammatory breast cancer or locally advanced breast cancer has completed, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-04-09